CRESCENT BIOPHARMA, INC. Capital Expenditures
CRESCENT BIOPHARMA, INC. (CBIO) reported Capital Expenditures of $160.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-30
- CRESCENT BIOPHARMA, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $13.00K, a 90.71% decline year-over-year.
- CRESCENT BIOPHARMA, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $147.00K.
- CRESCENT BIOPHARMA, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $193.00K.
- CRESCENT BIOPHARMA, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $586.00K.
- CRESCENT BIOPHARMA, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $919.00K, a 9115.80% increase from fiscal 2024.
- CRESCENT BIOPHARMA, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $9.97K, a 53.39% decline from fiscal 2023.
- CRESCENT BIOPHARMA, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $21.39K, a 74.59% decline from fiscal 2022.
- CRESCENT BIOPHARMA, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $84.19K, a 463.41% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 0 month | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 130 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $160.00K 10-Q · filed 2026-07-30 | $353.00K derived: sum of 3 quarters · filed 2026-07-30 | $939.00K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $147.00K 10-Q · filed 2026-04-29 | $340.00K derived: sum of 2 quarters · filed 2026-04-29 | $926.00K derived: sum of 3 quarters · filed 2026-04-29 | $1.07M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $779.00K derived: sum of 2 quarters · filed 2026-02-26 | $919.00K derived: sum of 3 quarters · filed 2026-07-30 | $919.00K 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $586.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $726.00K derived: sum of 2 quarters · filed 2026-07-30 | $726.00K 10-Q · filed 2025-11-06 | $726.00K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $140.00K 10-Q · filed 2026-07-30 | $140.00K derived: sum of 3 quarters · filed 2026-07-30 | $140.00K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-04-29 | $0.00 derived: sum of 2 quarters · filed 2026-04-29 | $0.00 derived: sum of 3 quarters · filed 2026-04-29 | $2.53K derived: sum of 4 quarters · filed 2026-04-29 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $2.53K derived: sum of 3 quarters · filed 2026-02-26 | $9.97K 10-K · filed 2025-02-13 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $2.53K derived: sum of 2 quarters · filed 2024-11-13 | $9.97K 10-Q · filed 2024-11-13 | $10.77K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-06-30 | $2.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $9.97K 10-Q · filed 2024-08-08 | $10.77K derived: sum of 3 quarters · filed 2025-05-14 | $18.64K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-03-31 | $7.44K 10-Q · filed 2025-05-14 | $8.24K derived: sum of 2 quarters · filed 2025-05-14 | $16.11K derived: sum of 3 quarters · filed 2025-05-14 | $26.64K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $801.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $8.67K derived: sum of 2 quarters · filed 2025-02-13 | $19.20K derived: sum of 3 quarters · filed 2025-02-13 | $21.39K 10-K · filed 2025-02-13 | ||
| 2023-09-30 | $7.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $18.40K derived: sum of 2 quarters · filed 2024-11-13 | $20.59K 10-Q · filed 2024-11-13 | $20.59K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $10.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $12.73K 10-Q · filed 2024-08-08 | $12.73K derived: sum of 3 quarters · filed 2024-08-08 | $15.21K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $2.20K 10-Q · filed 2024-05-09 | $2.20K derived: sum of 2 quarters · filed 2024-05-09 | $4.68K derived: sum of 3 quarters · filed 2024-05-09 | $45.87K derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.48K derived: sum of 2 quarters · filed 2024-03-27 | $43.67K derived: sum of 3 quarters · filed 2024-03-27 | $84.19K 10-K · filed 2024-03-27 | ||
| 2022-09-30 | $2.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $43.67K derived: sum of 2 quarters · filed 2023-11-03 | $84.19K 10-Q · filed 2023-11-03 | $86.64K derived: sum of 4 quarters · filed 2024-03-27 | ||
| 2022-06-30 | $41.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $81.71K 10-Q · filed 2023-08-02 | $84.15K derived: sum of 3 quarters · filed 2024-03-27 | $88.49K derived: sum of 4 quarters · filed 2024-03-27 | ||
| 2022-03-31 | $40.52K 10-Q · filed 2023-05-03 | $42.97K derived: sum of 2 quarters · filed 2024-03-27 | $47.30K derived: sum of 3 quarters · filed 2024-03-27 | $52.40K derived: sum of 4 quarters · filed 2024-03-27 | ||
| 2021-12-31 | $2.45K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $6.78K derived: sum of 2 quarters · filed 2024-03-27 | $11.88K derived: sum of 3 quarters · filed 2024-03-27 | $14.94K 10-K · filed 2024-03-27 | ||
| 2021-09-30 | $4.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $9.44K derived: sum of 2 quarters · filed 2022-11-09 | $12.50K 10-Q · filed 2022-11-09 | $50.67K derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2021-06-30 | $5.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $8.16K 10-Q · filed 2022-08-03 | $46.34K derived: sum of 3 quarters · filed 2023-03-29 | $62.15K derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2021-03-31 | $3.06K 10-Q · filed 2022-04-28 | $41.23K derived: sum of 2 quarters · filed 2023-03-29 | $57.05K derived: sum of 3 quarters · filed 2023-03-29 | $63.43K derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2020-12-31 | $38.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $53.99K derived: sum of 2 quarters · filed 2023-03-29 | $60.37K derived: sum of 3 quarters · filed 2023-03-29 | $68.51K 10-K · filed 2023-03-29 | ||
| 2020-09-30 | $15.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $22.20K derived: sum of 2 quarters · filed 2021-11-02 | $30.33K 10-Q · filed 2021-11-02 | $42.69K derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2020-06-30 | $6.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $14.52K 10-Q · filed 2021-08-05 | $26.88K derived: sum of 3 quarters · filed 2022-03-03 | $45.14K derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2020-03-31 | $8.14K 10-Q · filed 2021-05-03 | $20.49K derived: sum of 2 quarters · filed 2022-03-03 | $38.76K derived: sum of 3 quarters · filed 2022-03-03 | $113.53K derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2019-12-31 | $12.36K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $30.62K derived: sum of 2 quarters · filed 2022-03-03 | $105.39K derived: sum of 3 quarters · filed 2022-03-03 | $144.93K 10-K · filed 2022-03-03 | ||
| 2019-09-30 | $18.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $93.03K derived: sum of 2 quarters · filed 2020-11-06 | $132.57K 10-Q · filed 2020-11-06 | $189.57K derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-06-30 | $74.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $114.31K 10-Q · filed 2020-07-31 | $171.31K derived: sum of 3 quarters · filed 2021-03-02 | $197.87K derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-03-31 | $39.54K 10-Q · filed 2020-05-01 | $96.54K derived: sum of 2 quarters · filed 2021-03-02 | $123.10K derived: sum of 3 quarters · filed 2021-03-02 | $148.54K derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2018-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $83.56K derived: sum of 2 quarters · filed 2021-03-02 | $109.00K derived: sum of 3 quarters · filed 2021-03-02 | $125.62K 10-K · filed 2021-03-02 | ||
| 2018-09-30 | $26.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $52.00K derived: sum of 2 quarters · filed 2019-11-07 | $68.61K 10-Q · filed 2019-11-07 | $102.86K derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-06-30 | $25.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $42.05K 10-Q · filed 2019-08-01 | $76.30K derived: sum of 3 quarters · filed 2020-02-28 | $108.99K derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | $16.62K 10-Q · filed 2019-05-02 | $50.87K derived: sum of 2 quarters · filed 2020-02-28 | $83.55K derived: sum of 3 quarters · filed 2020-02-28 | $247.76K derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | $34.25K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $66.93K derived: sum of 2 quarters · filed 2020-02-28 | $231.14K derived: sum of 3 quarters · filed 2020-02-28 | $294.11K 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $32.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $196.89K derived: sum of 2 quarters · filed 2018-11-02 | $259.86K 10-Q · filed 2018-11-02 | $698.43K derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2017-06-30 | $164.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $227.17K 10-Q · filed 2018-08-09 | $665.74K derived: sum of 3 quarters · filed 2019-03-06 | $891.13K derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2017-03-31 | $62.97K 10-Q · filed 2018-05-03 | $501.54K derived: sum of 2 quarters · filed 2019-03-06 | $726.92K derived: sum of 3 quarters · filed 2019-03-06 | $749.90K derived: sum of 4 quarters · filed 2019-03-06 | ||
| 2016-12-31 | $438.57K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $663.95K derived: sum of 2 quarters · filed 2019-03-06 | $686.93K derived: sum of 3 quarters · filed 2019-03-06 | $704.20K 10-K · filed 2019-03-06 | ||
| 2016-09-30 | $225.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $248.37K derived: sum of 2 quarters · filed 2017-11-08 | $265.63K 10-Q · filed 2017-11-08 | $268.86K derived: sum of 4 quarters · filed 2018-03-06 | ||
| 2016-06-30 | $22.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $40.25K 10-Q · filed 2017-08-03 | $43.48K derived: sum of 3 quarters · filed 2018-03-06 | $101.87K derived: sum of 4 quarters · filed 2018-03-06 | ||
| 2016-03-31 | $17.27K 10-Q · filed 2017-05-08 | $20.50K derived: sum of 2 quarters · filed 2018-03-06 | $78.89K derived: sum of 3 quarters · filed 2018-03-06 | $283.52K derived: sum of 4 quarters · filed 2018-03-06 | ||
| 2015-12-31 | $3.23K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $61.62K derived: sum of 2 quarters · filed 2018-03-06 | $266.25K derived: sum of 3 quarters · filed 2018-03-06 | $268.59K 10-K · filed 2018-03-06 | ||
| 2015-09-30 | $58.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $263.03K derived: sum of 2 quarters · filed 2016-11-04 | $265.37K 10-Q · filed 2016-11-04 | $280.23K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $204.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $206.97K 10-Q · filed 2016-08-04 | $221.84K derived: sum of 3 quarters · filed 2017-03-01 | $323.84K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $2.34K 10-Q · filed 2016-05-04 | $17.20K derived: sum of 2 quarters · filed 2017-03-01 | $119.20K derived: sum of 3 quarters · filed 2017-03-01 | $201.02K derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $14.87K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $116.87K derived: sum of 2 quarters · filed 2017-03-01 | $198.68K derived: sum of 3 quarters · filed 2017-03-01 | $212.60K 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $183.82K derived: sum of 2 quarters · filed 2015-11-12 | $197.74K 10-Q · filed 2015-11-12 | $210.17K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $81.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $95.74K 10-Q · filed 2015-08-06 | $108.17K derived: sum of 3 quarters · filed 2016-02-29 | $147.34K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $13.92K 10-Q · filed 2015-05-05 | $26.35K derived: sum of 2 quarters · filed 2016-02-29 | $65.52K derived: sum of 3 quarters · filed 2016-02-29 | $89.19K derived: sum of 4 quarters · filed 2016-02-29 | $1.56M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $12.43K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $51.60K derived: sum of 2 quarters · filed 2016-02-29 | $75.27K derived: sum of 3 quarters · filed 2016-02-29 | $82.09K 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $39.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $62.84K derived: sum of 2 quarters · filed 2014-10-31 | $69.66K 10-Q · filed 2014-10-31 | |||
| 2013-06-30 | $23.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $30.49K 10-Q · filed 2014-07-31 | ||||
| 2013-03-31 | $6.82K 10-Q · filed 2014-05-09 | |||||
| 2012-12-31 | $316.18K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |